Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

'Mitochondrial transfer' into nerves could relieve chronic pain, early study hints

A new study reveals that nerve cells receive periodic infusions of mitochondria from neighboring cells — and this may point ...

Stimulating immune cell cleanup process may ease chronic pain after nerve injury

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...
Health on MSN

5 foods with more choline than eggs

Choline is an essential nutrient that plays a key role in fetal growth and development, supports cell structure and function, ...
TMCnet

Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis

Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing in the registrational PIONEER program across 2 key ...